Food and nutrition tracking app MyFitnessPal announced a new set of tools and content to support members taking GLP-1 medications by helping them maintain proper nutrition and consistency while experiencing weight loss. MyFitnessPal is a…
Continue Reading
Digital chronic-condition management company Lark Health announced the appointment of Darren Eckberg as its new chief growth officer who will lead the expansion of the company’s AI-enabled GLP-1 cost containment technology. The company offers health…
Continue Reading
Payers are always wary about funding new treatments for illnesses and conditions: When millions of dollars are at stake, payers want demonstrated improvements in outcomes. So do doctors and patients, before they go through…
Continue Reading
After Being Selected by Leading PBMs, Benefits Navigators, and Health Plans as the Virtual Cardiometabolic Provider of Choice, 9amHealth Increases the Round’s Total to $25M
9amHealth, the leading virtual provider for cardiometabolic health, announced it…
What You Should Know:
– Eli Lilly and Company (Lilly) and Amazon Pharmacy today announced a strategic collaboration to improve patient access to GLP-1 medications for diabetes, obesity, and migraines.
– The partnership aims to improve…
Continue Reading
What You Should Know:
Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as…
Continue Reading
Guy Friedman, co-founder and CEO of SteadyMD
The past few years have seen upheavals in healthcare, and 2024 so far shows no signs of breaking that pattern.
While the fundamentals of healthcare remain the same –…
Continue Reading
Omada, a virtual healthcare provider, announced Tuesday that it is expanding its GLP-1 companion solution to include musculoskeletal exercise programming and member-level reporting for employers, payers and pharmacy benefit managers.
San Francisco-based Omada serves employers,…
GLP-1 medications like Ozempic and Wegovy remain in high demand and continue to make headlines, even among mainstream media outlets. As the healthcare industry watches closely to see how payers decide to cover the…
Continue Reading
GLP-1 medications like Ozempic, Wegovy, and Mounjaro have ushered in a new era for the weight loss market in 2024 and surfaced several questions that have been festering for quite some time and can…
Continue Reading
